Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease attention deficit-hyperactivity disorder
Phenotype C0003467|anxiety
Sentences 11
PubMedID- 23096041 [attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options].
PubMedID- 24143189 Recent reports have shown that children born with iugr have long-term cognitive impairment and learning difficulties in school [13], [14], [17], [20], [22], being related to a characteristic pattern involving short-term memory, attention and anxiety, and increased risk of attention-deficit hyperactivity disorder (adhd) [13]–[15].
PubMedID- 22917126 To explore the relationship between sensory overresponsivity (sor) and anxiety in children with autism, attention deficit hyperactivity disorder, and typical development.
PubMedID- 21802745 Micronutrients reduce stress and anxiety in adults with attention-deficit/hyperactivity disorder following a 7.1 earthquake.
PubMedID- 24975621 The limited literature on neurofeedback research in children and adolescents is discussed regarding treatment of anxiety, mood, addiction (with comorbid attention-deficit/hyperactivity disorder), and traumatic brain injury.
PubMedID- 25260213 Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder.
PubMedID- 22854219 Data were extracted based on piu and psychopathology, including depression, anxiety, symptoms of attention deficit and hyperactivity disorder (adhd), obsessive-compulsive symptoms, social phobia and hostility/aggression.
PubMedID- 20349396 Comorbid psychological disorders (e.g., major depression and anxiety) among women with attention deficit-hyperactivity disorder were associated with increased impairment.
PubMedID- 24139217 Owing to the presence of secondary diagnoses indicating comorbidity of mood or anxiety disorders with hyperkinetic disorders, we further compared three groups of patients: 1) patients with mood or anxiety disorders, but not hyperkinetic disorders (denoted ma-group, n = 223), 2) patients with hyperkinetic disorders, but not mood or anxiety disorders (denoted h-group, n = 188), and 3) patients with hyperkinetic disorders and mood or anxiety disorders (denoted hma-group, n = 40).
PubMedID- 20952350 Objective: given sparse research on the issue, this study sought to shed light upon the interactions of alexithymia, emotion processing, and social anxiety in adults with attention-deficit hyperactivity disorder (adhd).
PubMedID- 24753534 anxiety in children with attention-deficit/hyperactivity disorder.

Page: 1